AngioDynamics Inc (ANGO)
5.70
+0.30
(+5.56%)
USD |
NASDAQ |
Mar 27, 16:00
5.71
+0.01
(+0.18%)
After-Hours: 20:00
AngioDynamics Research and Development Expense (Quarterly): 8.658M for Nov. 30, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
November 30, 2023 | 8.658M |
August 31, 2023 | 7.941M |
May 31, 2023 | 7.86M |
February 28, 2023 | 6.852M |
November 30, 2022 | 6.838M |
August 31, 2022 | 8.333M |
May 31, 2022 | 7.866M |
February 28, 2022 | 7.28M |
November 30, 2021 | 8.199M |
August 31, 2021 | 7.394M |
May 31, 2021 | 9.104M |
February 28, 2021 | 8.565M |
November 30, 2020 | 9.712M |
August 31, 2020 | 9.009M |
May 31, 2020 | 7.232M |
February 29, 2020 | 8.395M |
November 30, 2019 | 7.764M |
August 31, 2019 | 6.292M |
May 31, 2019 | 6.893M |
February 28, 2019 | 6.915M |
November 30, 2018 | 7.076M |
August 31, 2018 | 7.374M |
May 31, 2018 | 5.333M |
February 28, 2018 | 6.457M |
November 30, 2017 | 6.107M |
Date | Value |
---|---|
August 31, 2017 | 6.441M |
May 31, 2017 | 5.575M |
February 28, 2017 | 5.951M |
November 30, 2016 | 5.913M |
August 31, 2016 | 6.709M |
May 31, 2016 | 6.937M |
February 29, 2016 | 5.808M |
November 30, 2015 | 6.179M |
August 31, 2015 | 6.129M |
May 31, 2015 | 6.952M |
February 28, 2015 | 6.855M |
November 30, 2014 | 6.069M |
August 31, 2014 | 6.718M |
May 31, 2014 | 7.367M |
February 28, 2014 | 7.045M |
November 30, 2013 | 7.003M |
August 31, 2013 | 6.709M |
May 31, 2013 | 6.438M |
February 28, 2013 | 5.793M |
November 30, 2012 | 7.014M |
August 31, 2012 | 7.074M |
May 31, 2012 | 5.222M |
February 29, 2012 | 4.574M |
November 30, 2011 | 5.125M |
August 31, 2011 | 5.591M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
6.292M
Minimum
Aug 2019
9.712M
Maximum
Nov 2020
7.905M
Average
7.866M
Median
May 2022
Research and Development Expense (Quarterly) Benchmarks
Integer Holdings Corp | 13.26M |
Perspective Therapeutics Inc | 5.721M |
Xtant Medical Holdings Inc | 0.49M |
Asensus Surgical Inc | 8.614M |
Catheter Precision Inc | 0.112M |